文献速递生殖医学

核型定位:单中心应用该方法学的持续妊娠与活产率经验

Karyomapping: a single centre's experience from application of methodology to ongoing pregnancy and live-birth rates.
PubMed 文献 · Reprod Biomed Online · 2017-06-15

单中心研究评估核型定位用于单基因病和/或染色体结构重排的植入前遗传学诊断。608枚胚胎中,146枚(24%,95%CI 21-28)为第3天活检、462枚(76%,95%CI 72-79)为囊胚活检;81次移植中51次(63%,95%CI 52-73)为持续妊娠,6次(7%,95%CI 3-15)孕早期流产,24次(30%,95%CI 21-40)着床失败。作者认为核型定位可靠、高效、准确,并提供非整倍体筛查。

要点

  • 82对夫妇中75对(91.5%)因常染色体单基因病转诊,6对(7.3%)因X连锁病转诊。
  • 81次移植中51次(63%,95%CI 52-73)为持续妊娠。
  • 51次持续妊娠中15次(29%,95%CI 19-43)在撰写时已单胎活产。

核心结论

  • 作者认为核型定位对需要单基因病和/或染色体结构重排植入前遗传学诊断的夫妇可靠、高效且准确,并提供非整倍体筛查以减少流产和着床失败风险。

研究设计与样本

  • 单中心研究,评估核型定位应用于需要单基因病和/或染色体结构重排植入前遗传学诊断的夫妇。
  • 82对夫妇中75对(91.5%)因常染色体单基因病转诊,6对(7.3%)因X连锁病转诊,1对(1.2%)因单基因病和染色体结构重排转诊。

主要发现

  • 608枚胚胎中,146枚(24%,95%CI 21-28)为第3天活检,462枚(76%,95%CI 72-79)为囊胚活检。
  • 共81次胚胎移植,其中16次(20%)为第3天活检后移植,65次(80%)为囊胚活检并冻融胚胎移植。
  • 81次已知妊娠结局的移植中,51次(63%,95%CI 52-73)为持续妊娠,6次(7%,95%CI 3-15)为孕早期流产,24次(30%,95%CI 21-40)为着床失败。
  • 51次持续妊娠中,15次(29%,95%CI 19-43)在撰写时已单胎活产。
  • 未见产前、遗传学检测异常或出生时表型诊断的报告。

临床怎么用

  • 作者认为核型定位对需要单基因病和/或染色体结构重排植入前遗传学诊断的夫妇可靠、高效且准确,并提供非整倍体筛查以降低流产和着床失败风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study aimed to determine whether karyomapping can be applied to couples requiring preimplantation genetic diagnosis (PGD) for single gene disorder (SGD) and/or chromosomal rearrangement. 75/82 (91.5%) and 6/82 (7.3%) couples were referred for autosomal SGD and X-linked disease, respectively. One couple (1.2%) was referred for SGD and chromosomal rearrangement. Of 608 embryos, 146 (24%, 95% CI 21-28) day-3 and 462 (76%, 95% CI 72-79) blastocyst biopsies were performed. A total of 81 embryo transfers were performed; 16/81 (20%) were following day-3 embryo biopsy, 65/81 (80%) were following blastocyst biopsy and cryopreserved embryo transfer. Of 81 embryo transfers with known pregnancy outcome, 51 (63%, 95% CI 52-73) were on-going pregnancies, 6/81 (7%, 95% CI 3-15) resulted in first trimester miscarriages and 24/81 (30%, 95% CI 21-40) were failed implantations. Of the 51 on-going pregnancies, 15 (29%, 95% CI 19-43) couples had a singleton live birth at the time of write up. There have been no reports of abnormal prenatal, genetic testing or diagnosis of phenotype at birth. Karyomapping is reliable, efficient and accurate for couples requiring PGD for SGD and/or chromosomal rearrangement. Additionally, it provides aneuploidy screening, minimising risks of miscarriage and implantation failure.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Ben-Nagi J, Wells D, Doye K, et al. Karyomapping: a single centre's experience from application of methodology to ongoing pregnancy and live-birth rates. Reprod Biomed Online. 2017. PMID: 28648921. doi:10.1016/j.rbmo.2017.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。